4,200
edits
Arrhythmogenic Right Ventricular Cardiomyopathy: Difference between revisions
Jump to navigation
Jump to search
m
Arrhythmogenic Right Ventricular Cardiomyopathy (view source)
Revision as of 18:46, 12 April 2010
, 12 April 2010no edit summary
mNo edit summary |
mNo edit summary |
||
| Line 49: | Line 49: | ||
**ACE-inhibitors to prevent cardiac remodelling | **ACE-inhibitors to prevent cardiac remodelling | ||
*[[ICD]] implantation is recommended for the prevention of sudden cardiac death in patients with ARVC with documented sustained VT or VF who are receiving chronic optimal medical therapy. | *[[ICD]] implantation is recommended for the prevention of sudden cardiac death in patients with ARVC with documented sustained VT or VF who are receiving chronic optimal medical therapy. | ||
*[[ICD | *[[ICD]] implantation can be considered for the prevention of sudden cardiac death in patients with ARVC with extensive disease, including those with left ventricular involvement, 1 or more affected family member with SCD (Sudden Cardiac Death), or undiagnosed syncope when [[Ventricular Tachycardia|ventricular tachycardia]] or [[Ventricular Fibrillation|ventricular Fibrillation]] has not been excluded as the cause of syncope, who are receiving chronic optimal medical therapy, and who have reasonable expectation of survival with a good functional status for more than 1 y. | ||
*Radiofrequency [[ablation]] can be useful as adjunctive therapy in management of patients with ARVC with recurrent [[Ventricular Tachycardia|ventricular tachycardia]], despite optimal antiarrhythmic drug therapy. | *Radiofrequency [[ablation]] can be useful as adjunctive therapy in management of patients with ARVC with recurrent [[Ventricular Tachycardia|ventricular tachycardia]], despite optimal antiarrhythmic drug therapy. | ||